Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleResearch Article

Rituximab in Combination with CHOP, an Effective and Well-tolerated Salvage Regimen for Diffuse Large B-Cell Lymphoma

Yong Guan, Zhenxia Lu, Butong Sun, Lintao Bi and Pengyu Zhang
Chinese Journal of Clinical Oncology August 2007, 4 (4) 264-267; DOI: https://doi.org/10.1007/s11805-007-0264-8
Yong Guan
1Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alan099015{at}163.com
Zhenxia Lu
2Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Butong Sun
2Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lintao Bi
2Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pengyu Zhang
3Clinical Laboratory, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 4 no. 4 264-267
DOI 
https://doi.org/10.1007/s11805-007-0264-8

Published By 
Cancer Biology & Medicine
History 
  • Received March 25, 2007
  • Accepted July 27, 2007
  • Published online August 1, 2007.

Copyright & Usage 
Copyright © 2007 by Tianjin Medical University Cancer Institute & Hospital and Springer

Author Information

  1. Yong Guan1⇑
  1. 1Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China.
  1. Correspondence to: Yong Guan (Now working in Department of Radiotherapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China). E-mail: alan099015{at}163.com
  1. Zhenxia Lu2
  1. 2Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China
  1. Butong Sun2
  1. 2Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China
  1. Lintao Bi2
  1. 2Department of Hematology and Oncology, China-Japan Union Hospital, Changchun 130033, China
  1. Pengyu Zhang3
  1. 3Clinical Laboratory, Tianjin Medical University Cancer Institute & Hospital, Tianjin 300060, China.
View Full Text
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 4 (4)
Chinese Journal of Clinical Oncology
Vol. 4, Issue 4
August 2007
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rituximab in Combination with CHOP, an Effective and Well-tolerated Salvage Regimen for Diffuse Large B-Cell Lymphoma
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Rituximab in Combination with CHOP, an Effective and Well-tolerated Salvage Regimen for Diffuse Large B-Cell Lymphoma
Yong Guan, Zhenxia Lu, Butong Sun, Lintao Bi, Pengyu Zhang
Chinese Journal of Clinical Oncology Aug 2007, 4 (4) 264-267; DOI: 10.1007/s11805-007-0264-8

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rituximab in Combination with CHOP, an Effective and Well-tolerated Salvage Regimen for Diffuse Large B-Cell Lymphoma
Yong Guan, Zhenxia Lu, Butong Sun, Lintao Bi, Pengyu Zhang
Chinese Journal of Clinical Oncology Aug 2007, 4 (4) 264-267; DOI: 10.1007/s11805-007-0264-8
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Multi-Targeted Therapies in Non-Small Cell Lung Cancer
  • Radiotherapy in Non-Functioning Pituitary Macroadenoma: Mansoura Experience
  • Expression of the B-Cell Lymphoma/Leukemia 11A Gene in Malignant Hematological Cell Lines through Quantitative Reverse Transcription Polymerase Chain Reaction
Show more Research Article

Similar Articles

Keywords

  • large cell lymphoma
  • diffuse
  • Rituximab
  • CHOP regimen

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire